# William W. Busse

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-w-busse/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,744 |
| Field | Asthma and respiratory diseases |
| h-index | 127 |
| i10-index | 456 |
| Last Known Institution | University of Wisconsin–Madison |
| OpenAlex ID | https://openalex.org/A5044980958 |
| ORCID iD | https://orcid.org/0000-0003-2591-4696 |
| Works | 929 |

## Researcher papers

- [Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-2008/)
- [Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma](https://scholariq.org/papers/dupilumab-efficacy-and-safety-in-moderate-to-severe-uncontrolled-asthma/)
- [Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children](https://scholariq.org/papers/randomized-trial-of-omalizumab-anti-ige-for-asthma-in-inner-city-children/)
- [Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations](https://scholariq.org/papers/preseasonal-treatment-with-either-omalizumab-or-an-inhaled-corticosteroid-boost/)
- [Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial](https://scholariq.org/papers/management-of-asthma-based-on-exhaled-nitric-oxide-in-addition-to-guideline/)
- [Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma](https://scholariq.org/papers/liberty-asthma-quest-phase-3-randomized-double-blind-placebo-controlled-parallel/)
- [Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents](https://scholariq.org/papers/development-and-validation-of-the-composite-asthma-severity-index-an-outcome/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)
- [Inhalation and Respiratory Drug Delivery](https://scholariq.org/topics/inhalation-and-respiratory-drug-delivery/)

## Researcher university

- [University of Wisconsin–Madison](https://scholariq.org/institutions/university-of-wisconsin-madison/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.